TOCQUEVILLE ASSET MANAGEMENT L.P. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2016$318,000
-15.4%
42,907
-5.3%
0.00%
-20.0%
Q4 2015$376,000
-9.2%
45,292
-1.4%
0.01%
-16.7%
Q3 2015$414,000
-33.0%
45,942
-10.8%
0.01%
-14.3%
Q2 2015$618,000
+25.4%
51,506
+12.5%
0.01%
+16.7%
Q1 2015$493,00045,8000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders